Page last updated: 2024-12-10

ethamolin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

monoethanolamine oleate: used for treatment of pyogenic granuloma [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5282489
CHEMBL ID3989529
CHEBI ID178699
SCHEMBL ID146090
MeSH IDM0103491

Synonyms (83)

Synonym
CHEBI:178699
2-aminoethanol;(z)-octadec-9-enoic acid
(9z)-octadec-9-enoic acid - 2-aminoethanol (1:1)
ethanolamine oleate
thanomin
ccris 3324
oldamin
ethanolamine oleate [usan]
neosclerol
oleic acid monoethanolamine
beta-hydroxyethylammonium oleate
oleic acid, ethanolamine salt
oleic acid, monoethanolamine salt
varex
moramin
monoaethanolamini oleas
varicetin
neo-varicane
einecs 218-878-0
tindanol
fo-611
cis-9-octadecenoic acid, ethanolamine salt
monoethanolamine oleate
9-octadecenoic acid (z)-, compound with 2-aminoethanol (1:1)
monoetanolammina oleato [dcit]
monoethanolamini oleas [inn-latin]
oleic acid compound with 2-aminoethanol (1:1)
phlebocid
oleic acid, 2-aminoethanol salt
oleato de monoetanolaminio [inn-spanish]
monolate
oleate de monoethanolamine [inn-french]
D02276
2272-11-9
oldamin (tn)
ethanolamine oleate (usan)
ethamolin (tn)
monoethanolamine oleate (jan)
ethamolin
DB06689
monoethanolamini oleas
unii-u4ry8mrx7c
u4ry8mrx7c ,
oleic acid monoethanolamine salt
nsc 760382
ec 218-878-0
monoetanolammina oleato
esclerosina
oleato de monoetanolaminio
monoethanolamine oleate [inn]
antivariz
oleate de monoethanolamine
nsc-760382
9-octadecenoic acid (z)-, compd with 2-aminoethanol (1:1)
monoethanolamine oleate [jan]
ethanolamine oleate [mi]
ethanolamine oleate [vandf]
monoethanolamine oleate [who-dd]
ethanolamine oleate [orange book]
monoethanolamine oleate [mart.]
SCHEMBL146090
W-109765
DTXSID8023008 ,
CHEMBL3989529
2-aminoethan-1-ol oleate
ethanolamine-oleate
oleic acid ethanolamine salt
oleic acid (ethanolamine)
HY-B2096
CS-0017525
dtxcid503008
monoethanolamini oleas (inn-latin)
monoetanolamina (base)
monoethanolamine (base)
oleate de monoethanolamine (inn-french)
oleato de monoetanolamina
ethanolamine (base)
monoethanolamine oleate (mart.)
oleato de monoetanolaminio (inn-spanish)
c05bb01
(9z)-octadec-9-enoic acid; 2-aminoethan-1-ol
EN300-26249785
AKOS040753125

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"BO-EIS is a safe and effective for treatment of high-risk gastric fundal varices."( Efficacy and safety of balloon-occluded endoscopic injection sclerotherapy as a prophylactic treatment for high-risk gastric fundal varices: a prospective, randomized, comparative clinical trial.
Arakawa, T; Fujiwara, Y; Higuchi, K; Itani, A; Kuga, T; Nakamura, K; Okazaki, H; Shiba, M, 2002
)
0.31
" Our results demonstrate that B-RTO is an efficacious and safe treatment for children with isolated GFV."( Efficacy and safety of balloon-occluded retrograde transvenous obliteration for gastric fundal varices in children.
Hisamatsu, C; Kawasaki, R; Maeda, K; Yasufuku, M, 2008
)
0.35
"8%) experienced adverse events (AEs) related to EO, which included fever in 24 (53."( Short-Term Safety and Efficacy of Balloon-Occluded Retrograde Transvenous Obliteration Using Ethanolamine Oleate: Results of a Prospective, Multicenter, Single-Arm Trial.
Hidaka, H; Hirota, S; Kobayakawa, M; Koizumi, J; Kokubu, S; Mochida, S; Nishida, N; Tajima, T; Tanaka, N; Yasumoto, T, 2017
)
0.46

Compound-Compound Interactions

ExcerptReferenceRelevance
"This study was designed to assess the safety and effectiveness of ethanolamine oleate (EO) sclerotherapy combined with transarterial embolization using a liquid adhesive agent (n-butyl cyanoacrylate, NBCA) for treatment of extracranial arteriovenous malformations (AVMs)."( Ethanolamine oleate sclerotherapy combined with transarterial embolization using n-butyl cyanoacrylate for extracranial arteriovenous malformations.
Hagihara, M; Ikeda, S; Ishiguchi, T; Izumi, Y; Kamei, S; Katsuda, E; Kimura, J; Kitagawa, A; Ota, T, 2014
)
0.4
"EO sclerotherapy combined with transarterial embolization using NBCA is safe and effective for treating extracranial AVMs with an acceptable risk of minor complications."( Ethanolamine oleate sclerotherapy combined with transarterial embolization using n-butyl cyanoacrylate for extracranial arteriovenous malformations.
Hagihara, M; Ikeda, S; Ishiguchi, T; Izumi, Y; Kamei, S; Katsuda, E; Kimura, J; Kitagawa, A; Ota, T, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
long-chain fatty acidA fatty acid with a chain length ranging from C13 to C22.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1594144Inhibition of Escherichia coli GroEL expressed in Escherichia coliDH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured soluble pig heart MDH refolding by measuring MDH enzyme acti2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID1474167Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status2016Drug discovery today, Apr, Volume: 21, Issue:4
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
AID1474166Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index2016Drug discovery today, Apr, Volume: 21, Issue:4
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
AID1594145Inhibition of Escherichia coli GroEL expressed in Escherichia coli DH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured rhodanese refolding by measuring rhodanese enzyme activity 2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (280)

TimeframeStudies, This Drug (%)All Drugs %
pre-199062 (22.14)18.7374
1990's85 (30.36)18.2507
2000's59 (21.07)29.6817
2010's63 (22.50)24.3611
2020's11 (3.93)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 48.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index48.17 (24.57)
Research Supply Index5.95 (2.92)
Research Growth Index4.56 (4.65)
Search Engine Demand Index76.22 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (48.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials54 (16.46%)5.53%
Reviews17 (5.18%)6.00%
Case Studies88 (26.83%)4.05%
Observational2 (0.61%)0.25%
Other167 (50.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]